Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients. [electronic resource]
Producer: 20120217Description: 43-50 p. digitalISSN:- 1432-0843
- Adult
- Age Factors
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Body Surface Area
- Doxorubicin -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Monocytes -- metabolism
- Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Sarcoma, Kaposi -- drug therapy
- Sex Factors
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.